Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06891911 · ClinicalTrials.gov registry record · NA

Groceries for Residents of Southeastern USA to Stop Hypertension

A NA study of Hypertension and Cardiovascular Diseases, sponsored by Beth Israel Deaconess Medical Center.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06891911: Recruiting NA study of Hypertension and Cardiovascular Diseases, sponsored by Beth Israel Deaconess Medical Center.

NCT06891911 is a NA study of Hypertension and Cardiovascular Diseases that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 150 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06891911, a NA study of Hypertension and Cardiovascular Diseases, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

GoFreshSE is a randomized control trial, testing the effects of a home-delivered, dietitian-assisted, DASH-patterned grocery intervention on blood pressure in adults with high blood pressure in Florida, Georgia, and Tennessee.

Primary Outcome

This entails 4 measurements, 2 in the morning and 2 in the evening, over a 7 day period (at least 3 concurrent days is acceptable for analysis).

Interventions

  • BEHAVIORAL Dietitian-Assisted DASH groceries
  • BEHAVIORAL Self-directed shopping

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-10-14
Est. Completion 2026-06
Phase NA

What NCT06891911 shows while recruiting

NCT06891911 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower).

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Dietitian-Assisted DASH groceries is the first listed.

NCT06891911 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06891911 about?

NCT06891911 is a clinical study titled "Groceries for Residents of Southeastern USA to Stop Hypertension". GoFreshSE is a randomized control trial, testing the effects of a home-delivered, dietitian-assisted, DASH-patterned grocery intervention on blood pressure in adults with high blood pressure in Florida, Georgia, and Tennessee.

What is the current status of trial NCT06891911?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-10-14. Estimated completion is 2026-06.

What conditions does trial NCT06891911 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Elevated Blood Pressure, Dietary Intervention.

What interventions are being tested in trial NCT06891911?

The interventions under investigation include: Dietitian-Assisted DASH groceries (BEHAVIORAL), Self-directed shopping (BEHAVIORAL).

Who is sponsoring clinical trial NCT06891911?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06891911 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06891911's enrollment target sits among peer trials

150 247th of 470 higher than 217 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06891911, the US trial registry maintained by the National Library of Medicine. NCT06891911 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.